Regeneron Pharmaceuticals Inc
F:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
F:RGO
|
US |
|
AXA SA
OTC:AXAHF
|
FR |
|
D
|
DBV Technologies SA
XMUN:DBV
|
FR |
|
D
|
Denso Corp
SWB:DNO
|
JP |
|
C
|
Continental AG
F:CON
|
DE |
|
B
|
Bank of Nova Scotia
XBER:BKN
|
CA |
|
J
|
Jabil Inc
SWB:JBL
|
US |
|
U-Haul Holding Co
F:AUK0
|
US |
|
Alpha Services and Holdings SA
F:ACBB
|
GR |
|
R
|
Rush Enterprises Inc
NASDAQ:RUSHB
|
US |
|
B
|
British American Tobacco PLC
OTC:BTAFF
|
UK |
|
Asahi Group Holdings Ltd
F:ABW
|
JP |
|
H
|
Honeywell International Inc
DUS:ALD
|
US |
|
W
|
Wyndham Hotels & Resorts Inc
F:2WY
|
US |
|
A
|
AdvanSix Inc
SWB:960
|
US |
|
C
|
Cameco Corp
XMUN:CJ6
|
CA |
|
C
|
CME Group Inc
SWB:MX4A
|
US |
|
F
|
Fresenius SE & Co KGaA
LSE:0OO9
|
DE |
|
A
|
Applied Materials Inc
XBER:AP2
|
US |
|
NTT Data Corp
OTC:NTDTY
|
JP |
|
Roche Holding AG
SIX:RO
|
CH |
|
N
|
Nextera Energy Inc
SWB:FP3
|
US |
|
P
|
PTC Therapeutics Inc
F:P91
|
US |
|
C
|
CITIC Securities Co Ltd
SWB:CI9
|
CN |
Wall St Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RGO is 718.61 EUR with a low forecast of 549.25 EUR and a high forecast of 890.79 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
718.61
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 718.61 EUR with a low forecast of 549.25 EUR and a high forecast of 890.79 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
13%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
23%
The compound annual growth rate for Operating Income over the next 3 years is 23%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 15%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
15%
The compound annual growth rate for Net Income over the next 3 years is 15%.
